I see it every week. A woman in her late thirties presents with breakouts that never fully cleared after her teens, or cleared and then returned in her late twenties with a vengeance. She has been using the same products that worked for teenage acne. They are not working now.
That is because this is not the same condition.
Adult female acne follows distinct patterns driven by hormonal fluctuations rather than the microbiome disruption and excess sebum production that characterise adolescent comedonal presentations. Recognising those patterns changes how you assess, how you treat, and when you refer.
How Adult Female Acne Presents
Distribution is the first clinical indicator. Hormonal acne clusters along the jaw, chin, lower cheeks, and neck. This is the androgen-sensitive distribution. It contrasts with the T-zone and forehead dominance common in teenage acne.
Lesions tend to be deep, inflammatory, and painful. Cystic nodules are common. There is often minimal surface comedonal activity, which explains why patients report that retinoids and benzoyl peroxide have produced little improvement. The pathology is deeper than those actives reach most effectively when used in isolation.
The cyclical nature is the second indicator. Ask this question directly in every consultation: do the breakouts follow a pattern around your menstrual cycle? Most patients with hormonal acne will immediately confirm that flares worsen in the week before menstruation, then partially settle once bleeding begins. This is the luteal phase, when relative androgen dominance increases sebaceous gland activity in the lower face.
Many patients have never made that connection. Asking the question gives them a framework and gives you a clearer clinical picture in minutes.
The Androgen Connection
Sebaceous glands in the jaw and lower face carry high concentrations of androgen receptors. Even women with normal circulating androgen levels can experience localised sensitivity in this region. The receptors respond to even physiological fluctuations in androgens, driving localised sebum overproduction in the luteal phase.
In a subset of patients, systemic androgen excess is the driver. Polycystic ovary syndrome affects approximately 10% of women of reproductive age in the UK. Screening for it belongs in your consultation. Ask directly about cycle regularity, hirsutism, and difficulty managing weight. Patients with these additional features need GP referral before or alongside any aesthetic treatment. The skin presentation will not fully resolve without addressing the hormonal environment driving it.
Late-onset acne, meaning acne that begins for the first time after the age of 25 with no prior adolescent history, is worth flagging to the GP regardless. It is more likely to have a hormonal or drug-related cause worth investigating.
What UK Aesthetic Practitioners Can Appropriately Do
Scope of practice matters here. As aesthetic practitioners, we can support acne management through topical treatments and skin barrier care. The systemic treatments with the most evidence in hormonal acne, including the combined oral contraceptive pill, spironolactone, and isotretinoin, sit within prescribing scope. They require GP or dermatology referral.
Within aesthetic practice, azelaic acid is well placed. It targets the inflammatory cascade, does not disrupt the skin microbiome, and carries a recognised evidence base for inflammatory papular acne. NICE CKS lists it as a first-line topical option for acne vulgaris. Adapalene at 0.1% is now available over the counter in the UK and addresses follicular hyperkeratinisation, a key part of the acne cycle. Benzoyl peroxide remains useful for its antimicrobial activity, particularly in combination with adapalene.
There is one critical adaptation for adult female skin: reduce the emphasis on strong exfoliating acids and increase the focus on barrier repair. Adult female skin, particularly from the late thirties onward, often shows barrier compromise alongside the acne. Aggressive acid exfoliation in this context drives inflammation and can worsen both the acne and the post-inflammatory pigmentation that follows it. Gentle, lipid-replenishing formulations alongside targeted actives tend to produce better sustained outcomes.
On topical antibiotics: NICE antibiotic stewardship guidance advises against prolonged isolated use. If topical antibiotics are included in a plan, they should be combined with benzoyl peroxide and reviewed at 12 weeks. They are not a long-term solution for a hormonally driven condition.
Clear Referral Criteria
Refer to the GP when:
- The cyclical pattern is clear and consistent across multiple cycles
- You have identified any indicators of possible PCOS
- 12 weeks of appropriate topical treatment has not produced measurable improvement
- The patient presents with late-onset acne with no prior adolescent history
- Psychological distress is significant
A referral letter that documents the distribution, the cyclical pattern, and the treatment history given helps the GP reach a decision quickly.
Setting Accurate Expectations
Adult female acne responds more slowly than teenage acne to topical treatment. Hormonal fluctuations create a constantly shifting baseline, and treatment works against that background. Communicate this clearly at the first consultation. Patients who understand why the condition behaves differently are more likely to remain consistent with treatment and less likely to abandon it at six weeks when progress seems slow.
Post-inflammatory hyperpigmentation is a frequent complication, particularly in medium and darker skin tones. SPF50+ broad-spectrum protection, applied daily and year-round, reduces the risk and is part of the treatment plan.
If you want to develop a structured clinical framework for acne assessment, treatment hierarchy, and pathology, Acne Decoded covers the full clinical picture at CPD level and is built specifically for UK aesthetic practitioners.